Human WT1(Wilms Tumor Protein) ELISA Kit
To Order Contact us below: [email protected]
Human Wilms tumor protein(WT1) ELISA kit |
1-CSB-EL026158HU |
Cusabio |
-
EUR 964.80
-
EUR 6118.80
-
EUR 3244.80
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Wilms tumor protein(WT1) in samples from serum, plasma, tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Human WT1(Wilms tumor protein) ELISA Kit |
EH1321 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 9.375pg/ml |
Human WT1/ Wilms tumor protein ELISA Kit |
E2696Hu |
Sunlong |
1 Kit |
EUR 726 |
Human Wilms Tumor Protein(WT1)ELISA Kit |
GA-E0014HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human Wilms Tumor Protein(WT1)ELISA Kit |
GA-E0014HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Wilms Tumor Protein (WT1) ELISA Kit |
SEF116Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5677.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
SEF116Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 572.76 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
SEF116Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 766.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
SEF116Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3090.6 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
4-SEF116Hu |
Cloud-Clone |
-
EUR 5738.40
-
EUR 3031.20
-
EUR 768.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Wilms Tumor Protein (WT1) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Wilms Tumor Protein ELISA Kit (WT1) |
RK02530 |
Abclonal |
96 Tests |
EUR 625.2 |
Wilms Tumor Protein (WT1) Antibody |
20-abx131682 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Wilms Tumor Protein (WT1) Antibody |
20-abx178910 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Wilms Tumor Protein (WT1) Antibody |
20-abx178911 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Wilms Tumor Protein (WT1) Antibody |
20-abx178912 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Wilms Tumor Protein (WT1) Antibody |
20-abx175128 |
Abbexa |
|
|
|
Recombinant Wilms Tumor Protein (WT1) |
4-RPF116Hu01 |
Cloud-Clone |
-
EUR 356.54
-
EUR 218.40
-
EUR 1007.04
-
EUR 415.68
-
EUR 711.36
-
EUR 314.40
-
EUR 2337.60
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Wilms Tumor Protein expressed in: E.coli |
Recombinant Wilms Tumor Protein (WT1) |
4-RPF116Hu02 |
Cloud-Clone |
-
EUR 356.54
-
EUR 218.40
-
EUR 1007.04
-
EUR 415.68
-
EUR 711.36
-
EUR 314.40
-
EUR 2337.60
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Wilms Tumor Protein expressed in: E.coli |
WT1 Antibody (Wilms Tumor protein) |
F41819-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 165 |
WT1 Antibody (Wilms Tumor protein) |
F41819-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 379 |
Human Wilms Tumor 1 (WT1) ELISA Kit |
20-abx153501 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human Wilms Tumor 1 (WT1) ELISA Kit |
abx570884-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human Wilms Tumor 1 (WT1) Protein |
20-abx650641 |
Abbexa |
-
EUR 510.00
-
EUR 276.00
-
EUR 1378.80
-
EUR 594.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
ELISA kit for Human WT1 (Wilms Tumor Protein) |
ELK3382 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Wilms Tumor Protein from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
ELISA kit for Human Wilms tumor protein (WT1) |
KTE60017-48T |
Abbkine |
48T |
EUR 398.4 |
|
Description: Quantitative sandwich ELISA for measuring Human Wilms tumor protein (WT1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Wilms tumor protein (WT1) |
KTE60017-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
Description: Quantitative sandwich ELISA for measuring Human Wilms tumor protein (WT1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Wilms tumor protein (WT1) |
KTE60017-96T |
Abbkine |
96T |
EUR 646.8 |
|
Description: Quantitative sandwich ELISA for measuring Human Wilms tumor protein (WT1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Human Wilms Tumor Protein (WT1)CLIA Kit |
SCF116Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 6777.36 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
Human Wilms Tumor Protein (WT1)CLIA Kit |
SCF116Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 663.31 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
Human Wilms Tumor Protein (WT1)CLIA Kit |
SCF116Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 896.16 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
Human Wilms Tumor Protein (WT1)CLIA Kit |
SCF116Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3672.72 |
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
Human Wilms Tumor Protein (WT1) CLIA Kit |
4-SCF116Hu |
Cloud-Clone |
-
EUR 6837.60
-
EUR 3673.20
-
EUR 896.40
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1)Tissue homogenates and other biological fluids |
Mouse Wilms Tumor 1 (WT1) ELISA Kit |
abx515508-96tests |
Abbexa |
96 tests |
EUR 886.8 |
|
Pig Wilms Tumor 1 (WT1) ELISA Kit |
abx515509-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
Rat Wilms Tumor 1 (WT1) ELISA Kit |
abx515510-96tests |
Abbexa |
96 tests |
EUR 886.8 |
|
Wilms Tumor 1 (WT1) Antibody |
20-abx142313 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 376.80
|
|
|
Wilms Tumor 1 (WT1) Antibody |
20-abx001111 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Wilms Tumor 1 (WT1) Antibody |
20-abx116670 |
Abbexa |
|
|
|
Wilms Tumor 1 (WT1) Antibody |
20-abx334134 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Wilms Tumor 1 (WT1) Antibody |
abx224107-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
Wilms Tumor 1 (WT1) Antibody |
abx430953-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
Wilms Tumor 1 (WT1) Antibody |
abx239528-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
Wilms Tumor 1 (WT1) Antibody |
abx215781-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
WT1 Antibody / Wilms Tumor 1 |
V8166-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V8166-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V8166SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V8926-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. |
WT1 Antibody / Wilms Tumor 1 |
V8926-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. |
WT1 Antibody / Wilms Tumor 1 |
V8926SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. |
WT1 Antibody / Wilms Tumor 1 |
V9173-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. In tumor tissues, WT1 is detected in tumor cells of Wilms Tumor (also known as nephroblastoma) and mesothelioma. Additionally, WT1 expression has been found in ovarian serous carcinomas and some breast carcinomas. WT1 is particularly used for distinguishing malignant mesothelioma and ovarian serous carcinoma from non-serous carcinomas. |
WT1 Antibody / Wilms Tumor 1 |
V9173-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. In tumor tissues, WT1 is detected in tumor cells of Wilms Tumor (also known as nephroblastoma) and mesothelioma. Additionally, WT1 expression has been found in ovarian serous carcinomas and some breast carcinomas. WT1 is particularly used for distinguishing malignant mesothelioma and ovarian serous carcinoma from non-serous carcinomas. |
WT1 Antibody / Wilms Tumor 1 |
V9173SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. In tumor tissues, WT1 is detected in tumor cells of Wilms Tumor (also known as nephroblastoma) and mesothelioma. Additionally, WT1 expression has been found in ovarian serous carcinomas and some breast carcinomas. WT1 is particularly used for distinguishing malignant mesothelioma and ovarian serous carcinoma from non-serous carcinomas. |
WT1 Antibody / Wilms Tumor 1 |
V2930-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2930-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2930IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2930SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2931-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2931-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2931IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2931SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2932-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2932-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2932IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V2932SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V3610-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V3610-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V3610IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V3610SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7164-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
V7164-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
V7164IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
V7164SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
V7205-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7205-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7205IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7205SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7263-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7263-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7263IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7263SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
V7601-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
V7601-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
V7601IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
V7601SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
Rat Wt1/ Wilms tumor protein homolog ELISA Kit |
E1039Ra |
Sunlong |
1 Kit |
EUR 775.2 |
Mouse Wt1/ Wilms tumor protein homolog ELISA Kit |
E1600Mo |
Sunlong |
1 Kit |
EUR 758.4 |
Mouse Wilms tumor protein homolog, Wt1 ELISA KIT |
ELI-40533m |
Lifescience Market |
96 Tests |
EUR 1038 |
Porcine Wilms tumor protein homolog, WT1 ELISA KIT |
ELI-17852p |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Human Wilms Tumor 1 (WT1) CLIA Kit |
20-abx190177 |
Abbexa |
-
EUR 9493.20
-
EUR 5058.00
-
EUR 1167.60
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Wt1 ELISA Kit| Mouse Wilms tumor protein ELISA Kit |
EF016508 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Wt1 ELISA Kit| Rat Wilms tumor protein ELISA Kit |
EF019480 |
Lifescience Market |
96 Tests |
EUR 826.8 |
OVA Conjugated Wilms Tumor Protein (WT1) |
4-CPF116Hu21 |
Cloud-Clone |
-
EUR 474.82
-
EUR 250.80
-
EUR 1450.56
-
EUR 563.52
-
EUR 1007.04
-
EUR 393.60
-
EUR 3446.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Wilms Tumor Protein expressed in: Protein conjugation |
OVA Conjugated Wilms Tumor Protein (WT1) |
4-CPF116Mu21 |
Cloud-Clone |
-
EUR 474.82
-
EUR 250.80
-
EUR 1450.56
-
EUR 563.52
-
EUR 1007.04
-
EUR 393.60
-
EUR 3446.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Mouse Wilms Tumor Protein expressed in: Protein conjugation |
OVA Conjugated Wilms Tumor Protein (WT1) |
4-CPF116Ra21 |
Cloud-Clone |
-
EUR 474.82
-
EUR 250.80
-
EUR 1450.56
-
EUR 563.52
-
EUR 1007.04
-
EUR 393.60
-
EUR 3446.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Rat Wilms Tumor Protein expressed in: Protein conjugation |
Human Wilms Tumor 1 (WT1) Protein (OVA) |
20-abx651868 |
Abbexa |
-
EUR 678.00
-
EUR 309.60
-
EUR 1963.20
-
EUR 794.40
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human) |
4-PAF116Hu01 |
Cloud-Clone |
-
EUR 296.40
-
EUR 3012.00
-
EUR 750.00
-
EUR 372.00
-
EUR 256.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1) |
Wilms Tumor 1 (WT1) Antibody Pair |
abx117613-1pair5x96wellplates |
Abbexa |
1 pair (5x96 well plates) |
EUR 1212 |
|
Wilms Tumor 1 (WT1) Antibody (HRP) |
20-abx338311 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Wilms Tumor 1 (WT1) Antibody (FITC) |
20-abx338312 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Wilms Tumor 1 (WT1) Antibody (Biotin) |
20-abx338313 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
WT1 Antibody Cocktail / Wilms Tumor 1 |
V2933-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody Cocktail / Wilms Tumor 1 |
V2933-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody Cocktail / Wilms Tumor 1 |
V2933IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody Cocktail / Wilms Tumor 1 |
V2933SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
Mouse Wilms Tumor 1 (WT1) Protein (OVA) |
20-abx651869 |
Abbexa |
-
EUR 678.00
-
EUR 309.60
-
EUR 1963.20
-
EUR 794.40
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Wilms Tumor 1 (WT1) Protein (OVA) |
20-abx651870 |
Abbexa |
-
EUR 678.00
-
EUR 309.60
-
EUR 1963.20
-
EUR 794.40
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), APC |
4-PAF116Hu01-APC |
Cloud-Clone |
-
EUR 414.00
-
EUR 3930.00
-
EUR 1094.40
-
EUR 528.00
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with APC. |
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), Biotinylated |
4-PAF116Hu01-Biotin |
Cloud-Clone |
-
EUR 373.20
-
EUR 2952.00
-
EUR 872.40
-
EUR 457.20
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with Biotin. |
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), Cy3 |
4-PAF116Hu01-Cy3 |
Cloud-Clone |
-
EUR 502.80
-
EUR 5190.00
-
EUR 1410.00
-
EUR 654.00
-
EUR 301.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with Cy3. |
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), FITC |
4-PAF116Hu01-FITC |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with FITC. |
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), HRP |
4-PAF116Hu01-HRP |
Cloud-Clone |
-
EUR 379.20
-
EUR 3426.00
-
EUR 968.40
-
EUR 477.60
-
EUR 247.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with HRP. |
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), PE |
4-PAF116Hu01-PE |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with PE. |
Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), APC-Cy7 |
4-PAF116Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 685.20
-
EUR 7716.00
-
EUR 2046.00
-
EUR 912.00
-
EUR 382.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with APC-Cy7. |
Polyclonal WT1 / Wilms Tumor 1 Antibody (C-Terminus) |
APR02352G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human WT1 / Wilms Tumor 1 (C-Terminus). This antibody is tested and proven to work in the following applications: |
Polyclonal Goat Anti-Wilms tumor 1 / WT1 Antibody |
APG00365G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-Wilms tumor 1 / WT1 . This antibody is tested and proven to work in the following applications: |
ELISA kit for Human Wilms tumor protein |
EK2852 |
SAB |
96 tests |
EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Wilms tumor protein in samples from serum, plasma, tissue homogenates and other biological fluids. |
Wilms Tumor Protein Antibody |
48959-100ul |
SAB |
100ul |
EUR 399.6 |
Wilms Tumor Protein Antibody |
48959-50ul |
SAB |
50ul |
EUR 286.8 |
anti-Wilms Tumor Protein |
YF-PA15327 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to Wilms Tumor Protein |
Monoclonal WT1 / Wilms Tumor 1 Antibody (clone 1E9), Clone: 1E9 |
AMM02048G |
Leading Biology |
0.05mg |
EUR 633.6 |
Description: A Monoclonal antibody against Human WT1 / Wilms Tumor 1 (clone 1E9). The antibodies are raised in Mouse and are from clone 1E9. This antibody is applicable in WB and IHC-P, E |
Wilms Tumor Protein Conjugated Antibody |
C48959 |
SAB |
100ul |
EUR 476.4 |
Anti-Wilms Tumor Protein (2H4) |
YF-MA16074 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to Wilms Tumor Protein |
Anti-Wilms Tumor Protein (3B12) |
YF-MA16075 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to Wilms Tumor Protein |
Anti-Wilms Tumor Protein (1A12) |
YF-MA16076 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to Wilms Tumor Protein |
Anti-Wilms Tumor Protein (1E2) |
YF-MA16077 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to Wilms Tumor Protein |
Anti-Wilms Tumor Protein (1E9) |
YF-MA11010 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to Wilms Tumor Protein |
ELISA kit for Mouse Wilms tumor protein homolog |
EK2851 |
SAB |
96 tests |
EUR 804 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse Wilms tumor protein homolog in samples from serum, plasma, tissue homogenates and other biological fluids. |
Wilms Tumor 1 antibody |
70R-12541 |
Fitzgerald |
100 ul |
EUR 548.4 |
Description: Affinity purified Rabbit polyclonal Wilms Tumor 1 antibody |
Human Wilms tumor protein 1-interacting protein (WTIP) ELISA Kit |
abx251402-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human WTIP(Wilms tumor protein 1-interacting protein) ELISA Kit |
EH2071 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 46.9pg/ml |
Human WTIP/ Wilms tumor protein 1-interacting protein ELISA Kit |
E2698Hu |
Sunlong |
1 Kit |
EUR 685.2 |
Human Wilms tumor protein 1- interacting protein, WTIP ELISA KIT |
ELI-06581h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Human Wilms tumor protein 1-interacting protein(WTIP)ELISA kit |
YLA4432HU-48T |
Shanghai YL Biotech |
48T |
EUR 435 |
Human Wilms tumor protein 1-interacting protein(WTIP)ELISA kit |
YLA4432HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
Paraffin Tissue Section - Human Kidney Tumor: Wilms' Tumor |
T2235142-7 |
Biochain |
5 slides |
EUR 308.4 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Wilms Tumor Protein recombinant monoclonal antibody |
A5327 |
Bimake |
100ul X 3 |
EUR 714 |
|
Description: A recombinant monoclonal antibody from rabbit against human Wilms Tumor Protein for WB, IHC, IF,ELISA |
Wilms Tumor 1 Associated Protein Antibody |
20-abx116671 |
Abbexa |
|
|
|
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC040857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF405S conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC040857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF405S conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC050857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF405M conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC050857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF405M conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCAP0857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCAP0857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCB0857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Biotin conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCB0857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Biotin conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCP0857-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), PerCP conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCR0857-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), RPE conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC940857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF594 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC940857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF594 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCA0857-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), APC conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC810857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF680R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC810857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF680R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNUB0857-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Concentration: 0.2mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNUB0857-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Concentration: 0.2mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCH0857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNCH0857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC880857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF488A conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC880857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF488A conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC680857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF568 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC680857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF568 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC470857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF647 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC470857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF647 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC400857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF640R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC400857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF640R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC430857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF543 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC430857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF543 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC550857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF555 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC550857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF555 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC610857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF660R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC610857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF660R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC800857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF680 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC800857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF680 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC700857-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF770 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNC700857-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), CF770 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857) Antibody |
BNUM0857-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857), 1mg/mL |
Human Wilms Tumor 1 Associated Protein (WTAP) Protein |
20-abx168853 |
Abbexa |
-
EUR 644.40
-
EUR 292.80
-
EUR 1897.20
-
EUR 760.80
-
EUR 477.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Recombinant human Wilms tumor protein 1-interacting protein |
P1880 |
FN Test |
100ug |
Ask for price |
|
Description: Recombinant protein for human Wilms tumor protein 1-interacting protein |
Mouse Wilms tumor protein 1-interacting protein (WTIP) ELISA Kit |
abx519242-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Mouse Wilms tumor protein 1- interacting protein, Wtip ELISA KIT |
ELI-06580m |
Lifescience Market |
96 Tests |
EUR 1038 |
Wilms Tumor 1 Associated Protein (WTAP) Antibody |
20-abx131147 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Anti-Wilms Tumor Protein Rabbit Monoclonal Antibody |
M00199-1 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal Wilms Tumor Protein Antibody. Validated in IF, IHC, WB and tested in Human, Mouse. |
Recombinant Wilms Tumor 1 Associated Protein (WTAP) |
4-RPC245Hu01 |
Cloud-Clone |
-
EUR 459.77
-
EUR 246.00
-
EUR 1394.11
-
EUR 544.70
-
EUR 969.41
-
EUR 382.80
-
EUR 3305.28
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Wilms Tumor 1 Associated Protein expressed in: E.coli |
Wilms Tumor Protein 1-Interacting Protein (WTIP) Antibody |
abx037394-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC041138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF405S conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC041138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF405S conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCAP1138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCAP1138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCB1138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Biotin conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCB1138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Biotin conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCP1138-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), PerCP conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCR1138-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), RPE conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC941138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF594 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC941138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF594 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCA1138-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), APC conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC811138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF680R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC811138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF680R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNUB1138-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Concentration: 0.2mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNUB1138-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Concentration: 0.2mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCH1138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNCH1138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC881138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF488A conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC881138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF488A conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC611138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF660R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC611138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF660R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC681138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF568 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC681138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF568 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC431138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF543 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC431138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF543 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC471138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF647 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC471138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF647 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC401138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF640R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC401138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF640R conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC551138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF555 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC551138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF555 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC801138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF680 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC801138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF680 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC051138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF405M conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC051138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF405M conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC701138-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF770 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNC701138-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), CF770 conjugate, Concentration: 0.1mg/mL |
WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2) Antibody |
BNUM1138-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against WT1 (Wilm's Tumor 1)(WT1/857 + 6F-H2), 1mg/mL |
Wilms Tumor 1 Associated Protein (WTAP) Polyclonal Antibody (Human) |
4-PAC245Hu01 |
Cloud-Clone |
-
EUR 296.40
-
EUR 3012.00
-
EUR 750.00
-
EUR 372.00
-
EUR 256.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor 1 Associated Protein (WTAP) |
Human WT1(Wilms Tumor Protein) ELISA Kit